A detailed history of State Of Alaska, Department Of Revenue transactions in Biolife Solutions Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 20,553 shares of BLFS stock, worth $420,719. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,553
Previous 21,351 3.74%
Holding current value
$420,719
Previous $457,000 12.47%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$19.19 - $26.52 $15,313 - $21,162
-798 Reduced 3.74%
20,553 $514,000
Q2 2024

Aug 05, 2024

SELL
$15.14 - $22.99 $4,965 - $7,540
-328 Reduced 1.51%
21,351 $457,000
Q1 2024

Apr 19, 2024

BUY
$15.35 - $18.82 $4,298 - $5,269
280 Added 1.31%
21,679 $402,000
Q4 2023

Jan 19, 2024

BUY
$8.99 - $16.86 $62 - $118
7 Added 0.03%
21,399 $347,000
Q3 2023

Oct 16, 2023

SELL
$10.81 - $22.96 $16,031 - $34,049
-1,483 Reduced 6.48%
21,392 $295,000
Q2 2023

Jul 24, 2023

SELL
$17.19 - $24.34 $9,506 - $13,460
-553 Reduced 2.36%
22,875 $505,000
Q1 2023

Apr 17, 2023

SELL
$17.67 - $26.07 $6,979 - $10,297
-395 Reduced 1.66%
23,428 $509,000
Q4 2022

Jan 11, 2023

BUY
$16.95 - $25.07 $3,813 - $5,640
225 Added 0.95%
23,823 $433,000
Q3 2022

Oct 20, 2022

BUY
$14.64 - $26.7 $7,320 - $13,350
500 Added 2.16%
23,598 $536,000
Q2 2022

Jul 08, 2022

BUY
$10.54 - $24.2 $23,609 - $54,208
2,240 Added 10.74%
23,098 $318,000
Q1 2022

Apr 14, 2022

BUY
$20.81 - $37.29 $2,289 - $4,101
110 Added 0.53%
20,858 $474,000
Q4 2021

Jan 12, 2022

SELL
$32.99 - $58.55 $15,340 - $27,225
-465 Reduced 2.19%
20,748 $773,000
Q3 2021

Oct 07, 2021

BUY
$42.03 - $60.5 $891,582 - $1.28 Million
21,213 New
21,213 $897,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $874M
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.